Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Start for free
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
Rezolute rises as drug shows promise for rare low blood sugar disorders
Shares of drug developer Rezolute RZLT.O rise 2.1% to $1.95 premarketCo says late-stage trial of ersodetug in congenital hyperinsulinism missed main goals but showed drug activityCongenital HI causes frequent severe drops in blood sugar; all 59 patients opted for extension study, RZLT saysSome child...
Reuters
Wed, Jan 7
Could Buying XRP Today Set You Up for Life?
Key PointsXRP hit a 52-week high of $3.65 in mid-2025, but still finished the year trading near $2.New spot XRP ETFs launched in November, paving the way for institutional investors to gain exposure to XRP.Further integration of XRP into the global financial system could help send it soaring in pric...
The Motley Fool
Wed, Jan 7
RPT-European stocks pause rally as traders assess Venezuela fallout ahead of data
Jan 7 (Reuters) - European stocks steadied on Wednesday after a streak of record closes, as investors took a breather to digest the latest U.S.-Venezuela developments ahead of a batch of fresh economic data.The STOXX 600 index .STOXX rose 0.1% by 0804 GMT, a day after notching a record closing high....
Reuters
Wed, Jan 7
Arrowhead Pharma slips after unveiling convertible, stock deals
Arrowhead Pharmaceuticals ARWR.O shares down 2.3% before the bell to $69.20 as co seeks capital Drug developer late Tues announced public offering of $500 mln 6-year convertible bonds (CBs) and $200 mln stock deal Co intends to use net proceeds from offerings for general purposes, including wo...
Reuters
Wed, Jan 7
Red Spruce Capital Nets $3.7 Million by Dumping One-Third of BSCR Shares
Key PointsSold 185,157 shares of BSCR; estimated trade size $3.65 million (based on average fourth-quarter 2025 price).Quarter-end position value declined by $3.37 million, reflecting both the sale and stock price effects.Transaction represented 1.46% of reportable AUM.Post-sale stake: 317,620 share...
The Motley Fool
Wed, Jan 7
CANADA STOCKS-TSX futures dip as investors weigh new US-Venezuela developments, key data in focus
Jan 7 (Reuters) - Futures linked to Canada's main stock index inched lower on Wednesday, after two consecutive sessions of record highs, as investors assessed new U.S.-Venezuela developments and awaited key economic data releases.March futures on Toronto's S&P/TSX Composite index SXFcv1 ...
Reuters
Wed, Jan 7
Can XRP Get Back to $3 in 2026?
Key PointsXRP's potential to transform global payments has made it one of the leading cryptocurrencies in the world.Last year saw the launch of multiple exchange-traded funds that make it easier to invest in XRP.Challenging market conditions, however, could weigh down the entire crypto market in 202...
The Motley Fool
Wed, Jan 7
Pre-Bell | S&P, Nasdaq Futures Inch Lower; Ventyx Biosciences Rockets 60%; Mobileye Surges 10%; Critical Metals Rises 8%; Precious Metals Shares Pull Back
01 Stock MarketAs of Jan 7, U.S. stock index futures are mixed, indicating a cautious tone before the opening bell. Dow futures edged higher, with the front contract up 0.04% at 49,741.00, while S&P 500 futures fell 0.07% to 6,982.75 and Nasdaq 100 futures fell 0.19% to 25,773. The setup suggests te...
Tiger News
Wed, Jan 7
Monte Rosa rises as heart drug shows promise in early-stage trial
Shares of drug developer Monte Rosa Therapeutics GLUE.O rise 18.6% to $19 premarketCo says its experimental pill, MRT-8102, sharply lowered inflammation in people at risk for heart disease in an early-stage trialCo's MRT-8102 cut inflammation marker CRP by 85% in high-risk patients, says coCRP i...
Reuters
Wed, Jan 7
LIVE MARKETS-UK housebuilders at a tipping point
STOXX 600 little changedDAX hits new recordEnergy, luxury stocks lagWall St futures lowerWelcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com UK HOUSEBUILDERS AT A TIPPING POINTUK hou...
Reuters
Wed, Jan 7
Hershey rises after Piper Sandler upgrades to 'overweight'
Shares of chocolate maker Hershey HSY.N rise 1.3% to $181.59 in premarket trading Piper Sandler upgrades stock to "overweight" from "neutral" ratingBrokerage says lower cocoa costs and the removal of tariffs give co more room to invest in growth and still raise profits faster than us...
Reuters
Wed, Jan 7
US STOCKS-S&P 500, Nasdaq futures inch lower after AI-driven rally; labor data in focus
Futures: Dow up 0.05%, S&P 500 down 0.09%, Nasdaq down 0.22%Strategy gains as MSCI keeps crypto treasury firms in indexesMobileye rises after $900 million deal for Mentee ADP's December data on private sector employment due at 8:15 a.m. ETBy Purvi Agarwal and Nikhil Sharma Jan 7 (Reuters)...
Reuters
Wed, Jan 7
U.S. STOCKS ON THE MOVE-Colgate, Strategy, AAR Corp
The Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://refini.tv/3dKUyB8Futures linked to the S&P 500 and the Nasdaq inched lower on Wednesday, as investors took a pause after the S&P 500 and the Dow hit record highs in the previous session, while cautio...
Reuters
Wed, Jan 7
Prediction: Why Virgin Galactic Stock Is Set to Go to $0
Key PointsVirgin Galactic’s expenses are far outpacing its current revenues.Although management’s long-term model is impressive, it assumes flawless execution and very favorable luxury market conditions.While the company has succeeded in extending maturities with debt restructuring, it has increased...
The Motley Fool
Wed, Jan 7
PRECIOUS-Gold drops on profit-taking, stronger dollar
Gold slipped 1%ADP employment report due at 1315 GMT Silver slides 2.5%, palladium down 4.1%, platinum falls 4.8%By Pablo Sinha Jan 7 (Reuters) - Gold prices fell on Wednesday as investors booked profit following a months-long rally that saw the yellow metal smash records, while a slightly stron...
Reuters
Wed, Jan 7
Prediction: Solana Will Hit $200 in 2026
Key PointsSolana is positioned to have a great 2026.But there's a big new risk that wasn't around before late 2025.Demand for the coin will probably increase despite the new risk. 10 stocks we like better than Solana › I predict that by the end of 2026, Solana's (CRYPTO: SOL) price will be at or mor...
The Motley Fool
Wed, Jan 7
Warner Bros rejects revised Paramount bid as risky leveraged buyout
Warner Bros favors Netflix deal, spurning Paramount's amended bidParamount's bid includes $40 billion guarantee from Larry EllisonAnalysts see Netflix's offer as clearer with fewer execution risksBy Dawn Chmielewski, Kritika Lamba and Dawn Kopecki LOS ANGELES, Jan 7 (Reuters) - Warner...
Reuters
Wed, Jan 7
RPT-BREAKINGVIEWS-US Venezuela attack complicates Beijing LatAm push
By Ka Sing Chan HONG KONG, Jan 7 (Reuters Breakingviews) - For Latin America’s leaders, Washington's snatching of the Venezuelan president will make deepening ties with Beijing both more appealing and more fraught. Nicolas Maduro was, in his own words, "kidnapped" by U.S. troops just ...
Reuters
Wed, Jan 7
4 Ways Retirees Can Spend Less on Healthcare in 2026
Key PointsHealthcare can be a huge expense for older Americans.It's important to understand how your Medicare plan works this year.Consider a new plan if your current coverage is costing you more than expected.The $23,760 Social Security bonus most retirees completely overlook › There are certain ex...
The Motley Fool
Wed, Jan 7
Infosys and Cognition Announce Strategic Collaboration to Accelerate the AI Value Journey for Global Enterprises
Integrated capabilities of AI Software Engineer Devin and Infosys Topaz Fabric™ to accelerate software development, boost engineering productivity, and deliver faster time-to-market SAN FRANCISCO and BENGALURU, India, Jan. 7, 2026 /PRNewswire/ -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a...
PR Newswire
Wed, Jan 7
1
...
296
297
298
299
300
next page
KeyAI
Please log in to use KeyAI
Log in
Start for free